Amiel E. Gilad

542 total citations
6 papers, 371 citations indexed

About

Amiel E. Gilad is a scholar working on Surgery, Infectious Diseases and Pathology and Forensic Medicine. According to data from OpenAlex, Amiel E. Gilad has authored 6 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 1 paper in Infectious Diseases and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Amiel E. Gilad's work include Bladder and Urothelial Cancer Treatments (3 papers), Urinary and Genital Oncology Studies (2 papers) and Neuroblastoma Research and Treatments (1 paper). Amiel E. Gilad is often cited by papers focused on Bladder and Urothelial Cancer Treatments (3 papers), Urinary and Genital Oncology Studies (2 papers) and Neuroblastoma Research and Treatments (1 paper). Amiel E. Gilad collaborates with scholars based in Israel, Canada and United States. Amiel E. Gilad's co-authors include Mark Schoenberg, Pierre I. Karakiewicz, Shahrokh F. Shariat, Yair Lotan, Craig Rogers, Patrick J. Bastian, Amnon Vazina, Ganesh S. Palapattu, Seth P. Lerner and Arthur I. Sagalowsky and has published in prestigious journals such as The Journal of Urology, The Prostate and Journal of Surgical Oncology.

In The Last Decade

Amiel E. Gilad

6 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amiel E. Gilad Israel	4	280	118	101	78	50	6	371
Chih‐Hsiung Kang Taiwan	9	286 1.0×	60 0.5×	113 1.1×	81 1.0×	30 0.6×	17	377
Michael D. Kinnaman United States	7	217 0.8×	92 0.8×	105 1.0×	66 0.8×	17 0.3×	13	312
S. Holmäng Sweden	7	446 1.6×	121 1.0×	79 0.8×	100 1.3×	19 0.4×	17	500
Maria Angélica Mendoza Rodriguez United States	9	171 0.6×	35 0.3×	91 0.9×	96 1.2×	31 0.6×	13	283
Roberto Contieri Italy	11	231 0.8×	100 0.8×	117 1.2×	43 0.6×	54 1.1×	63	361
N. Piazza Italy	6	359 1.3×	138 1.2×	71 0.7×	71 0.9×	12 0.2×	7	380
Soloway Ms United States	11	212 0.8×	80 0.7×	110 1.1×	59 0.8×	25 0.5×	24	331
Thomas Schnöller Germany	5	192 0.7×	93 0.8×	45 0.4×	50 0.6×	13 0.3×	10	275
David Kakiashvili Canada	9	360 1.3×	79 0.7×	77 0.8×	52 0.7×	9 0.2×	20	380
R.H. Clayman United States	8	437 1.6×	227 1.9×	78 0.8×	133 1.7×	19 0.4×	19	512

Countries citing papers authored by Amiel E. Gilad

Since Specialization

Citations

This map shows the geographic impact of Amiel E. Gilad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amiel E. Gilad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amiel E. Gilad more than expected).

Fields of papers citing papers by Amiel E. Gilad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amiel E. Gilad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amiel E. Gilad. The network helps show where Amiel E. Gilad may publish in the future.

Co-authorship network of co-authors of Amiel E. Gilad

This figure shows the co-authorship network connecting the top 25 collaborators of Amiel E. Gilad. A scholar is included among the top collaborators of Amiel E. Gilad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amiel E. Gilad. Amiel E. Gilad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Nativ, Omri, et al.. (2024). Analysis of clinical characteristics, treatment patterns, and outcome of patients with bilateral testicular germ cell tumors. Discover Oncology. 15(1). 30–30. 1 indexed citations

2.

Nativ, Omri, et al.. (2020). Association between PSA density and pathologically significant prostate cancer: The impact of prostate volume. The Prostate. 80(16). 1444–1449. 60 indexed citations

3.

Rogers, Craig, Ganesh S. Palapattu, Shahrokh F. Shariat, et al.. (2006). Clinical Outcomes Following Radical Cystectomy for Primary Nontransitional Cell Carcinoma of the Bladder Compared to Transitional Cell Carcinoma of the Bladder. The Journal of Urology. 175(6). 2048–2053. 126 indexed citations

4.

Karakiewicz, Pierre I., Shahrokh F. Shariat, Ganesh S. Palapattu, et al.. (2006). Nomogram for Predicting Disease Recurrence After Radical Cystectomy for Transitional Cell Carcinoma of the Bladder. The Journal of Urology. 176(4). 1354–1362. 154 indexed citations

5.

Briganti, Alberto, Shahrokh F. Shariat, Yair Lotan, et al.. (2006). COMPETING RISKS NOMOGRAM PREDICTING THE PROBABILITY OF BLADDER CANCER RECURRENCE AFTER CYSTECTOMY CAN RELIABLY DISTINGUISH BETWEEN TUMOURS DESTINED TO RECUR AND PATIENTS WHO MAY DIE OF OTHER CAUSES BEFORE RECURRENCE. European Urology Supplements. 5(2). 38–38. 1 indexed citations

6.

Gilad, Amiel E., et al.. (1987). Surgery for carcinoma of the breast in women over 70 years of age. Journal of Surgical Oncology. 35(3). 180–183. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact